EMR
Errol M. Rudman Portfolio holdings
AUM
$148M
This Quarter Return
+7.36%
1 Year Return
+19.48%
3 Year Return
+61.39%
5 Year Return
+121.52%
10 Year Return
–
AUM
$206M
AUM Growth
+$206M
(+18%)
Cap. Flow
+$21.4M
Cap. Flow
% of AUM
10.39%
Top 10 Holdings %
Top 10 Hldgs %
56.47%
Holding
45
New
11
Increased
8
Reduced
2
Closed
3
Top Buys
| 1 |
Sherwin-Williams
SHW
|
$6.15M |
| 2 |
Lumen
LUMN
|
$6.09M |
| 3 |
GE Aerospace
GE
|
$3.49M |
| 4 |
McKesson
MCK
|
$3.12M |
| 5 |
Dentsply Sirona
XRAY
|
$2.63M |
Top Sells
| 1 |
LVLT
Level 3 Communications Inc
LVLT
|
$14.3M |
| 2 |
United Airlines
UAL
|
$1.13M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$880K |
| 4 |
Tenet Healthcare
THC
|
$411K |
| 5 |
TransDigm Group
TDG
|
$100K |
Sector Composition
| 1 | Industrials | 30.82% |
| 2 | Healthcare | 24.58% |
| 3 | Consumer Discretionary | 9.78% |
| 4 | Financials | 8.92% |
| 5 | Materials | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
SPDR S&P Biotech ETF
XBI
$5.07B
| $2.55M | 1.23% |
30,000
| – | – |
|
27
iShares Biotechnology ETF
IBB
$5.6B
| $2.4M | 1.16% |
22,500
+15,000
| +200% | +$1.6M |
|
28
Entegris
ENTG
$12.7B
| $2.35M | 1.14% |
77,291
| – | – |
|
|
CBPO
29
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $2.26M | 1.1% |
28,701
+1,800
| +7% | +$142K |
|
30
Sealed Air
SEE
$4.78B
| $1.97M | 0.96% |
40,000
| – | – |
|
31
MongoDB
MDB
$25.7B
| $1.96M | 0.95% |
+66,000
| New | +$1.96M |
|
32
Cognex
CGNX
$7.38B
| $1.84M | 0.89% |
30,000
+15,000
| +100% | +$918K |
|
33
Cal-Maine
CALM
$5.61B
| $1.78M | 0.86% |
+40,000
| New | +$1.78M |
|
34
ASML
ASML
$292B
| $1.74M | 0.84% |
10,000
| – | – |
|
35
JPMorgan Chase
JPM
$829B
| $1.71M | 0.83% |
+16,000
| New | +$1.71M |
|
36
Citigroup
C
$178B
| $1.49M | 0.72% |
+20,000
| New | +$1.49M |
|
37
Thermo Fisher Scientific
TMO
$186B
| $1.42M | 0.69% |
7,500
| – | – |
|
|
CCMP
38
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $1.22M | 0.59% |
13,000
| – | – |
|
39
ProShares Ultra Gold
UGL
$575M
| $1.2M | 0.58% |
29,500
| – | – |
|
40
Henry Schein
HSIC
$8.44B
| $1.05M | 0.51% |
+15,000
| New | +$1.05M |
|
41
Barclays
BCS
$68.9B
| $981K | 0.48% |
+90,000
| New | +$981K |
|
42
Wells Fargo
WFC
$263B
| $910K | 0.44% |
+15,000
| New | +$910K |
|
|
43
Teva Pharmaceuticals
TEVA
$21.1B
| – | – |
-50,000
| Closed | -$880K |
|
|
44
Tenet Healthcare
THC
$16.3B
| – | – |
-25,000
| Closed | -$411K |
|
|
LVLT
45
DELISTED
Level 3 Communications Inc
LVLT
| – | – |
-268,417
| Closed | -$14.3M |
|